The Medical Career of JeanMarie Guenot


LinkedIn shows that JeanMarie Guenot has been working in the pharmaceutical industry for over twenty years. She has a long track record of success in management and research. Her career trajectory has always been upwards. Dr. Guenot has worked in both the public and private sectors. She has a diverse amount of experience that includes working in research and development of pharmaceuticals, corporate development, commercial development, development of business, and more. She has extensive expertise in building and rebuilding businesses.


Dr. Guenot began her business career with Atlas Venture. At Atlas Venture she managed venture capital investments and created life science companies. Her career as a scientist began with preclinical research and development at Hoffmann-La Roche. During her tenure there she helped develop drugs for autoimmune diseases, oncology, metabolic diseases, and more. She earned her Ph.D at the University of California at San Francisco with specializations in fields including but not limited to physical and medicinal chemistry, protein structure prediction, and X-Ray and NMR refinement.  All of this is covered in detail on Jeanmarie’s CrunchBase page here:


JeanMarie Guenot is currently the President and CEO of Amphivena Therapeutics. Amphivena Therapeutics develops therapies and medications for hematologic malignancies. They have been in operation since 2012. In July of 2013 Amphivena Therapeutics announced that it had raised fourteen million dollars of Series A financing. Further, it announced a deal with Janssen Biotech, Inc the grants Janssen the exclusive right to acquire Amphuvena Therapeutics pending IND approval.


In April of 2015 Amphivena announced that is had reached the first two milestones in its agreement with Janssen. Amphivena Therapeutics and Janssen Biotech announced they had selected clinical candidate for an unannounced tumor antigen. This allowed payouts from Janssen to Amphivena. Jeanmarie Guenot gave an interview stating her excitement at the prospect of the new medication and the partnership with Janssen Biotec. She also stated her optimism for the treatment that will soon be tested.

Takeda’s website has more information on Amphivena and Jeanmarie Guenot’s new partnership.

Leave a Reply